Oric Pharmaceuticals (NASDAQ: ORIC) CFO sells 77,000 shares
Rhea-AI Filing Summary
Oric Pharmaceuticals, Inc. (ORIC) reported that Chief Financial Officer Dominic Piscitelli exercised stock options and sold shares on August 26, 2026. He exercised options for 52,000 shares of common stock at $4.36 per share and 25,000 shares at $6.00 per share, acquiring a total of 77,000 common shares. On the same date, he sold 77,000 common shares at an average price of $13.6859 per share in transactions effected pursuant to a Rule 10b5-1 trading plan adopted on May 26, 2026. One option grant includes a vesting schedule where 25% vested on February 1, 2024 and the remaining shares vest monthly thereafter. A referenced common stock position includes 1,680 shares acquired under Oric’s 2020 Employee Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 77,000 shares ($677K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Piscitelli Dominic
Role
Chief Financial Officer
Sold
77,000 shs ($1.05M)
Approx. gross sale proceeds
$1.05M
Approx. exercise cost
$377K
Approx. pre-tax spread
$677K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 52,000 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F3 | 25,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 52,000 | $4.36 | $227K |
| Exercise | Common Stock | 25,000 | $6.00 | $150K |
| Sale | Common Stock F2 | 77,000 | $13.6859 | $1.05M |
Holdings After Transaction:
Stock Option (right to buy) — 212,500 shares (Direct);
Common Stock — 69,828 shares (Direct)
Footnotes (3)
- F1. Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
- F2. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.
- F3. 25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
Key Figures
Common shares sold: 77,000 shares
Sale price per share: $13.6859 per share
Option exercise shares: 52,000 shares
+5 more
8 metrics
Common shares sold
77,000 shares
Sale of common stock on August 26, 2026
Sale price per share
$13.6859 per share
Average price for 77,000 common shares sold on August 26, 2026
Option exercise shares
52,000 shares
Stock option exercised at $4.36 per share into common stock
Option exercise price
$4.36 per share
Exercise price for 52,000-share stock option
Second option exercise shares
25,000 shares
Stock option exercised at $6.00 per share into common stock
Second option exercise price
$6.00 per share
Exercise price for 25,000-share stock option
ESPP shares included
1,680 shares
Common stock acquired under the 2020 Employee Stock Purchase Plan
10b5-1 plan adoption date
May 26, 2026
Date CFO adopted Rule 10b5-1 trading plan for reported sales
Key Terms
Rule 10b5-1 trading plan, Stock Option (right to buy), Employee Stock Purchase Plan, vesting, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Employee Stock Purchase Plan financial
"acquired under the Issuer's 2020 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
vesting financial
"25% of the shares subject to the option vested on February 1, 2024"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
FAQ
What did ORIC CFO Dominic Piscitelli report in this Form 4?
He reported exercising options for 77,000 Oric Pharmaceuticals (ORIC) common shares at $4.36 and $6.00 per share, and selling 77,000 common shares at an average price of $13.6859 per share on August 26, 2026.
What stock options did the ORIC CFO exercise in this filing?
He exercised two stock option awards: one for 52,000 shares of Oric common stock at an exercise price of $4.36 per share and another for 25,000 shares at $6.00 per share, all reported as exercised on August 26, 2026.
What is the vesting schedule for one of the ORIC option grants?
For the 25,000-share option grant, the Form 4 notes that 25% of the shares vested on February 1, 2024, and 1/36th of the remaining shares vest each month thereafter, reflecting a standard monthly vesting schedule over three years.
What are the expiration dates of the ORIC stock options exercised?
The 52,000-share option at $4.36 per share expires on July 19, 2032. The 25,000-share option at $6.00 per share expires on January 31, 2033, as reported in the Form 4 option transaction details.
Does the ORIC Form 4 mention the Employee Stock Purchase Plan?
Yes. A referenced common stock holding includes 1,680 shares of Oric common stock that were acquired under the company’s 2020 Employee Stock Purchase Plan, according to a footnote in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
